ARCHIVES

FDA Approves Novartis Drug Zometa For Multiple Myeloma And Bone Mets.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

Genentech Reps Not Welcome: Hospitals Urge Drug Maker to Reverse Policy On Supplying Avastin, Rituxan, & Herceptin

October 17, 2014

Gigliotti Appointed Chief of Education Branch In DRCCA

January 21, 1983

Corrections Made To NCI Phone Directory

May 17, 1991

Racial Differences In Survival Increase According To Stage

August 31, 2007

St. Jude, Washington University Plan $65 Million Pediatric Cancer Genome Project

January 29, 2010

Biomedical Research Advocates Temper Budget Requests In View Of War, Deficit.

January 28, 2005